This weekend, Chris Evert tweeted that she was diagnosed with early-stage (Stage 1C) ovarian cancer, which is associated with an outstanding survival rate. This news is especially good because most people diagnosed with ovarian cancer are diagnosed at stage III or IV,...
In today’s episode we take a look at some of the significant challenges and errors we are seeing in the use of genetic and genomic testing, as they become mainstreamed into our clinical treatment protocols. Today we highlight the Top Errors in Genetic Testing...
On January 1, The New York Times published an article, “When They Warn of Rare Disorders, These Prenatal Tests Are Usually Wrong,” followed by a discussion with the author on their popular podcast, The Daily, entitled, “An Investigation into Flawed...
The leading healthcare and precision medicine companies are focused on commercial growth that relies on genome-driven personalization of healthcare, and for that, they are turning to digital health technology companies. The race to build a comprehensive suite of...
For some, it may seem like certain types of cancers “run in the family.” This can be due to shared behaviors or exposures that increase cancer risk, or an abnormal genetic change that’s passed down from generation to generation. Over the past 25...
